| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 06/04/2009 | CA2706929A1 Novel naphthyridine derivative monohydrate and method for producing the same |
| 06/03/2009 | EP2065388A1 Pyrazolopyrimidine derivative |
| 06/03/2009 | EP2065379A1 Benzimidazole compound having gastric acid secretion inhibitory activity |
| 06/03/2009 | CN100494202C Spirofuropyridine aryl derivatives |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | CA2503900C Purine compounds and use thereof as cannabinoid receptor ligands |
| 06/02/2009 | CA2474205C E2 displacement assay for identifying inhibitors of hpv |
| 06/02/2009 | CA2425395C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 05/28/2009 | WO2009067392A1 Cyclopropyl fused indolobenzazepine derivatives for the treatment of hepatitis c |
| 05/28/2009 | US20090137596 G-protein inhibitor |
| 05/28/2009 | CA2706391A1 Spiropiperidines for use as tryptase inhibitors |
| 05/28/2009 | CA2705599A1 New compounds |
| 05/27/2009 | EP2061763A2 Process for the preparation of substituted-1,2,3,4-tetrahydroisoquinoline derivates |
| 05/27/2009 | EP1679747B1 Organic thin film transistor |
| 05/27/2009 | CN101443336A Cyclopropyl fused indolobenzazepine HVC ns5b inhibitors |
| 05/27/2009 | CN101443323A Substituted spirocyclic CGRP receptor antagonists |
| 05/27/2009 | CN101440099A Industrial large scale extracting method for nimbin dry powder |
| 05/27/2009 | CN100491378C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 05/27/2009 | CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/26/2009 | US7538104 Photoactivable nitrogen bases |
| 05/22/2009 | WO2009064418A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 05/22/2009 | WO2009062288A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705312A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2704436A1 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 05/21/2009 | US20090131655 Cephem Compounds Having Broad Antibacterial Spectrum |
| 05/20/2009 | EP2060574A1 Heterocyclic compound and an organic light emitting device comprising the same |
| 05/20/2009 | EP2060272A2 Vitamin-mitomycin conjugates |
| 05/20/2009 | CN101437829A Bisadenosine compounds as adenosine A2A receptor agonists |
| 05/20/2009 | CN101437516A Treatment of diseases using nalmefene and its analogs |
| 05/20/2009 | CN101433565A Total alkaloid extract of seeds of harmel genus and effective monomer component thereof, and preparation and use thereof |
| 05/20/2009 | CN100488923C Double-loop coil organic compounds and electric-field luminescent devices |
| 05/14/2009 | WO2009061453A1 Solubilized thiazolopyridines |
| 05/14/2009 | WO2009060742A1 Organic electroluminescent device, display device, and illuminating device |
| 05/14/2009 | WO2009060158A1 4- (4-cyanophenyl) -1- (3-trifluoromethylphenyl) -3,4, 6, 7-tetrahydro-1h-pyrrolo [3, 4- d] pyrimidine-2, 5-dione derivatives and their use as human neutrophil elastase inhibitors |
| 05/14/2009 | US20090121617 Electronic devices made with electron transport and/or anti-quenching layers |
| 05/14/2009 | CA2705138A1 Solubilized thiazolopyridines |
| 05/13/2009 | EP2058314A1 Pyrrolotriazine compounds as kinase inhibitors |
| 05/13/2009 | CN101432278A Diketo-piperazine and piperidine derivatives as antiviral agents |
| 05/12/2009 | US7531546 inhibitors of cysteine proteases; neuropathic pain, inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis, tumors, obesity, coronary disease, atherosclerosis; 6-(2-Acetyl-2,8-diaza-spiro[4.5]dec-8-ylmethyl)-7-(2-cyclohexyl-ethyl)-7H-pyrrolo[2,3d]pyrimidine-2-carbonitrile |
| 05/12/2009 | US7531320 Modulation of β-catenin/TCF-activated transcription |
| 05/12/2009 | CA2517933C Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors |
| 05/06/2009 | EP2054422A1 Acrylamide derivatives as fab i inhibitors |
| 05/06/2009 | EP2054421A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 05/06/2009 | EP1326865B1 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101423524A Diglutamate derivates and application thereof in preparation of pemetrexed |
| 05/06/2009 | CN100484945C Method for preparing cefozopran hydrochloride, cefozopran hydrochloride powder injection and preparation method thereof |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528126 viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease; e.g. 1,1'[[(Propane-1,3-diyl)dioxy]bis(11aS)-11-sulpho-7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4-benzodiazepin-5-one]] sodium salt |
| 05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 04/30/2009 | WO2009054332A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 04/30/2009 | WO2009053716A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | WO2009053715A1 Thienopyrimidiene derivatives as pi3k inhibitors |
| 04/30/2009 | US20090112002 Process for preparation of aldonic acids and derivatives thereof |
| 04/30/2009 | US20090111699 Weakly Basic Hindered Amines Having Carbonate Skeletons, Synthetic Resin Compositions, And Coating Compositions |
| 04/30/2009 | CA2703489A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 04/30/2009 | CA2703138A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | CA2701276A1 Thienopyrimidiene derivatives as pi3k inhibitors |
| 04/29/2009 | EP2053051A1 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element |
| 04/29/2009 | EP2051715A2 Modulators of muscarinic receptors |
| 04/29/2009 | EP1537123B1 Amino-substituted cyclohexane derivatives for the treatment of bacterial infections |
| 04/29/2009 | CN101421282A Treatment of hyperproliferative diseases with vinca alkaloidn-oxide and analogs |
| 04/28/2009 | US7524951 Intermediates of 2-substituted carbapenem derivatives and process for production thereof |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/23/2009 | WO2009052145A1 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors |
| 04/23/2009 | WO2009050248A1 Substituted piperidino-dihydrothienopyrimidines |
| 04/23/2009 | WO2009050242A2 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 04/23/2009 | WO2009050236A1 Novel piperazino-dihydrothienopyrimidine derivatives |
| 04/23/2009 | WO2006029167A3 Treatment of diseases using nalmefene and its analgos |
| 04/23/2009 | US20090105229 Purine derivatives as kinase inhibitors |
| 04/23/2009 | CA2705414A1 Substituted piperidino-dihydrothienopyrimidines |
| 04/23/2009 | CA2702838A1 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors |
| 04/23/2009 | CA2702524A1 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 04/23/2009 | CA2702518A1 New piperazino-dihydrothienopyrimidine derivatives |
| 04/22/2009 | EP2050751A1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| 04/22/2009 | EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 04/22/2009 | EP2049547A2 Aza-peptide protease inhibitors |
| 04/22/2009 | CN101415708A HIV inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/22/2009 | CN100480249C Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 04/22/2009 | CN100479824C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 04/21/2009 | US7521571 Compounds such as 2-thioisosorbide 5-mononitrate or 5,5'-dinitrate-2,2'-dithiodiisosorbide or 2-methylthioisosorbide 5-mononitrate; cardiovascular diseases such as, atherosclerosis, cardiac allograft vasculopathy, and tissue damage due to ischemia and/or to ischemia-reperfusion |
| 04/16/2009 | WO2009049028A1 Pyrrolopyrimidine compounds and their use as janus kinase modulators |
| 04/15/2009 | EP2046803A1 Imidazothiazole derivatives as mark inhibitors |
| 04/15/2009 | EP2046799A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them |
| 04/15/2009 | CN101410397A Organic compounds |
| 04/15/2009 | CN100478343C Purine compound and use as cannabinoid receptor ligands |
| 04/15/2009 | CN100478031C The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 04/14/2009 | US7518905 High density memory device |
| 04/14/2009 | US7518000 For therapy of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK); 2-(1H-thieno[3,2-c]pyrazol-3-yl)-1H-benzimidazole |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517904 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 04/14/2009 | US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 04/09/2009 | WO2009016286A3 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 04/09/2009 | US20090093457 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 04/09/2009 | CA2700903A1 Parp inhibitor compounds, compositions and methods of use |
| 04/08/2009 | EP2045252A2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 04/08/2009 | EP2044082A1 Substituted benzodithiophenes and benzodiselenophenes |
| 04/08/2009 | EP2044077A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |